Metropolis Health shares rise nearly 5% post positive Q3 business update

Shares of Metropolis Healthcare Ltd. gained over 4% on Monday, January 5, after the company reported its third quarter business update.

The company said its consolidated revenue increased 26% from the previous year, driven by sustained momentum in preventive and wellness checkups under TruHealth, along with a strong increase in specialty testing volumes across both B2C and B2B channels.

It said it has successfully scaled its specialty business across its pan-India network, supported by an expanded core diagnostics test menu for high-end specialty testing and continuous in-house innovation.

The TruHealth Wellness and Specialty segments

recorded 35% and 33% growth in the third quarter, respectively.

The company's B2C revenues increased 18% while its B2B revenue growth stood at 37% on the back of addition of wallet share among customers, especially for specialty segment and on account of higher contribution of B2B business in core diagnostics, it said.

On a standalone basis, Metropolis Health's revenue grew around 15% on account of increased patient and test volumes and a favourable shift in product mix and realisations.

TruHealth Wellness and specialty segments grew 23% and 16%, respectively.

B2C revenues witnessed a 14% growth, while the B2B segment rose 16%.

The company said its EBITDA margins for the December quarter expanded from the previous year, despite the quarter being a seasonally-weaker period for the diagnostic industry.

Metropolis Health shares were up 4.6% at ₹2,021.4 apiece around 11.55 am on Monday. 

Also Read: Metal Stock Picks For 2026: Jefferies highlights three names for up to 26% upside